How much is Antios Therapeutics worth in 2026?

Antios Therapeutics has a current valuation of N/A based on their Early Stage VC (Series B1) round and secondary market data.

How much funding has Antios Therapeutics raised?

Antios Therapeutics has raised N/A in total funding across 1 funding rounds.

Antios Therapeutics

Drug Discovery

Antios Therapeutics valuation and funding history | Last updated: November 3, 2021 | 1 funding rounds

Current Valuation

N/A

As of November 3, 2021

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC (Series B1)

$75.0M

Last Funding

Nov 2021

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
November 3, 2021	Early Stage VC (Series B1)	$75.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Antios Therapeutics is currently valued at N/A as of November 3, 2021.

Track Antios Therapeutics Valuation Updates

Get notified when Antios Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Antios Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Antios Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Antios Therapeutics Worth in 2026?

Antios Therapeutics is a leading private company in the Drug Discovery sector. Track Antios Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Antios Therapeutics Valuation is Determined

Private company valuations like Antios Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.